Riskpilot← Back to searchSign inGet full accessKARMSUND PROTEIN AS
ASActiveOrg 916768257Husøyvegen 141, 4262 AvaldsnesProcessing and preserving of fish, crustaceans and molluscs · NACE 1020Est. 201623 employees
Revenue 2024
NOK 596,9M
+13% vs 2023
EBITDA margin
16.0%
+4% vs 2023
Equity ratio
53.1%
Financial strength
Net profit 2024
NOK 32,4M
+4% vs 2023
| Revenue | NOK 596,9M | +13% |
| EBITDA | NOK 95,5M | +4% |
| Net profit | NOK 32,4M | +4% |
| Total assets | NOK 534,4M | +5% |
| Equity | NOK 283,6M | +9% |
| Employees | 23 | — |
Legal name
KARMSUND PROTEIN AS
Org number
916768257
Legal form
Aksjeselskap
NACE code
1020 · Processing and preserving of fish, crustaceans and molluscs
Founded
19. februar 2016
Share capital
NOK 359 940
Employees
23 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Kjøp og salg av fiskeprodukter, samt hva hermed står i forbindelse, herunder å delta i andre foretak med tilsvarende virksomhet.
Address
Husøyvegen 141, 4262 Avaldsnes
Phone
+4799212438
Email
post@karmsundprotein.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 480 305 | 343 843 | 391 193 | 527 875 | 596 903 |
| Staff expenses | −20 975 | −21 349 | −24 099 | −25 170 | −23 064 |
| EBITDA | 32 469 | −2 684 | 95 124 | 91 709 | 95 527 |
| Depreciation & amort. | −12 480 | −12 801 | −92 970 | −35 434 | −37 786 |
| EBIT | 19 989 | −15 485 | 2 154 | 56 276 | 57 742 |
| Net financials | −15 835 | −12 756 | −15 131 | −16 386 | −16 718 |
| Profit before tax | 4 154 | −28 241 | −12 977 | 39 890 | 41 024 |
| Tax | 914 | −6 212 | −2 852 | 8 776 | 8 593 |
| Net profit | 3 240 | −22 029 | −10 125 | 31 114 | 32 431 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 648 742 | 549 156 | 533 440 | 508 623 | 534 427 |
| Equity | 261 253 | 239 224 | 229 099 | 260 213 | 283 646 |
| Long-term debt | 291 803 | 265 029 | 241 697 | 227 948 | 212 791 |
| Short-term debt | 95 686 | 44 903 | 62 643 | 20 462 | 37 991 |
| Total debt | 387 489 | 309 932 | 304 340 | 248 410 | 250 782 |
EBITDA margin
16.0%
This company
15.8%
Market median
+1% vs market
20202024
Equity ratio
53.1%
This company
38.2%
Market median
+39% vs market
20202024
Return on equity
11.4%
This company
18.4%
Market median
+38% vs market
20202024
Net profit margin
5.4%
This company
8.1%
Market median
-33% vs market
20202024
Asset turnover
1.12×
This company
1.12×
Market median
+0% vs market
20202024
Debt / equity
0.88×
This company
0.62×
Market median
+42% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AB Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (4) | ||
GO Deputy Member | Deputy Member | 2020 – 2022 |
AH Deputy Member | Deputy Member | 2020 – 2022 |
ØS Chief Executive Officer | Chief Executive Officer | 2018 – 2022 |
MØ Deputy Member | Deputy Member | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Former (3) | ||
| Board of Directors | 2020 – 2022 | |
| Board of Directors | 2022 – 2025 | |
| Chairman | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 51.05% | 51.05% | 2022 | |
| Company | 51.05% | 51.05% | 2024 | |
| Company | 48.95% | 48.95% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Thore As
KARMSUND PROTEIN AS Board members of KARMSUND PROTEIN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Geir Olav Stang | Deputy Member | 0 companies |
| Arnt-Ove Blytt-Tøsdal Kolås | Chief Executive Officer | 0 companies |
| Arne Harald Stensland | Deputy Member | 0 companies |
| Øyvind Stang | Chief Executive Officer | 0 companies |
| Marlen Østervold Haugland | Deputy Member | 0 companies |
| Peter Olav Midthun | Board of Directors | 0 companies |
| Egil Magne Haugstad | Chairman | 0 companies |
| Aleksander Vedø | Board of Directors | 0 companies |
| Arve Henning Hystad | Board of Directors | 0 companies |
| Mads Torrissen | Chairman | 0 companies |